Knight Capital Group’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Knight Capital Group’s Portfolio SVNT Stock Details SVNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$29K	Buy	+49,313	New	+$34.4K	﹤0.01%	3136

Other funds holding SVNT

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knight Capital Group's SVNT Position: Q2 2013 in Review

Knight Capital Group opened a new position in SAVIENT PHARMACEUTICALS INC (SVNT) in Q2 2013: 49,313 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #3136 among its holdings.

47 funds tracked by Wall St. Rank hold SVNT as of Q2 2013.

Knight Capital Group held 49,313 shares of SAVIENT PHARMACEUTICALS INC worth $29K as of Q2 2013.
SAVIENT PHARMACEUTICALS INC was a new Knight Capital Group position in Q2 2013.
SAVIENT PHARMACEUTICALS INC made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3136 holding.
47 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.